PUBLICATIONS

Clinical Research Focus. 38th Edition Discrepancies in AI Clinical Trial Reporting: A Call for Transparency A new eClinicalMedicine study highlights inconsistencies between AI clinical trial results reported in registries and published in journals. Selective reporting of secondary outcomes and adverse events raises concerns about evidence reliability. Researchers emphasize the need for stricter adherence to reporting guidelines to improve transparency in Read more

Regulatory Pathways for Rare Disease Drug Development: What Sponsors Need to Know – Rare Disease Day Special With over 440 million people worldwide affected by rare diseases, each breakthrough brings new hope. But how can sponsors accelerate treatments while navigating complex regulations? On Rare Disease Day 2025, we explore key regulatory pathways that can fast-track life-changing therapies. What Are Rare and Ultra-Rare Diseases? Rare diseases are conditions that affect a small percentage Read more

Bulgaria: A Rising Hub for Clinical Research in Europe Bulgaria may not be the first country that comes to mind when considering a hub for cutting-edge clinical research. However, this Balkan nation has been steadily gaining recognition as a key player in the industry. With a thriving clinical trials sector valued at approximately $330 million, Bulgaria ranks among the top 20 countries globally in Read more

Key Takeaways from SCOPE 2025: Insights from Cromos Pharma’s US Business Development Director With the conclusion of the 16th Annual Summit for Clinical Operations Executives (SCOPE) held from February 3-6, 2025, in Orlando, industry experts shared key insights into the future of clinical research and development. This year’s discussions centered on artificial intelligence, decentralized clinical trials (DCTs), localization, and strategies for improving efficiency and diversity in clinical trials. Read more